Since a combination of flt3 ligand plasmid (pFL) and CpG-oligodeoxynucleotides (ODN) 3
as a dendritic cell (DC)-targeting double mucosal adjuvant elicited ovalbumin-specific …

The considerable advances made in the fields of molecular biology, genomics, proteomics
and protein engineering have led to the identification of a vast range of potential vaccine …

Human respiratory syncytial virus (HRSV) is a leading cause of lower respiratory tract
infections in elderly individuals and young children/infants and can cause bronchiolitis and …

Mutations of influenza virus increase concerns of worldwide epidemics resulting from the
newly emergent strains. Current influenza vaccines are inefficient and require annual …

Abstract Development of an effective vaccine against leishmaniasis is possible due to the
fact that individuals cured from cutaneous leishmaniasis (CL) are protected from further …

Background: We previously showed that Toll‐like receptor‐9 (TLR‐9) ligands ameliorate
experimental colitis. In this study, we evaluated the effect of TLR‐9 ligands on the generation …

DNA vaccines have proven to be an efficient means of inducing immune responses in small
laboratory animals; however, their efficacy in large out-bred animal models has been much …

Human respiratory syncytial virus (RSV) is the most significant cause of acute lower
respiratory infection in children. However, there is no licensed vaccine available. Here, we …

The current Bacille Calmette–Guérin vaccine provides variable protection against
tuberculosis and new vaccination approaches are urgently needed. Pulmonary vaccination …

Brucella abortus, a gram negative, facultative intracellular pathogen causes brucellosis in
many animal species and humans. Although live, attenuated vaccines are available against …